AllSquare Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-109
Closed 509
2020
Q4
$0 Hold
109
﹤0.01% 496
2020
Q3
$0 Hold
109
﹤0.01% 495
2020
Q2
$0 Buy
+109
New +$393 ﹤0.01% 502

Other funds holding BMY.RT

AllSquare Wealth Management's BMY.RT Position: Q1 2021 in Review

AllSquare Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 109 shares.

AllSquare Wealth Management first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $0 in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • AllSquare Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • AllSquare Wealth Management sold 109 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • AllSquare Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
  • AllSquare Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $0 in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on AllSquare Wealth Management's 13F filing for Q1 2021, filed 11 May 2021.